Yemaachi Biotech Analysis
What is Yemaachi Biotech?
Yemaachi Biotech focuses on creating a comprehensive cancer bio-database to develop innovative cancer drugs. Their unique approach emphasizes inclusivity and diversity in cancer research, particularly for populations in Africa. This work aims to transform cancer care and improve outcomes for diverse patient groups globally.
Location
1 Round House Road, Abelemkpe, Accra, Ghana
Employees
11-50
Founded
2020
Industry
Yemaachi Biotech Operates In The Biotechnology Industry, Specifically Focusing On Cancer Research And Drug Development. This Industry Involves The Use Of Biological Processes And Organisms To Create Products And Technologies That Improve Health Outcomes. Yemaachi Biotech Is Dedicated To Developing Next-generation Cancer Drugs And Conducting Genomic Research To Understand Cancer Variations, Particularly For Diverse Populations In Africa. Their Work Aims To Enhance Precision Oncology Practices And Transform Cancer Care Through Inclusive Research And Collaboration With Global Partners.
Revenue
$2.8-6.2M
Business Model
Pure Industrial Software
Funding Status
Series A
HQ Location
Accra, Ghana
YC Batch
S21
Product Features & Capabilities
- GeneStrat™ EGFR ctDNA, non-invasive blood-based test for NSCLC, fast and accurate results, supports treatment decisions
- Sheba HPV Test, self-sampling and molecular diagnostics for HPV screening, detects 15 cancer-causing strains
- SMA Genetic Testing Program, free blood test for Spinal Muscular Atro
Use Cases
Develop next-generation cancer drugs for diverse populations; Conduct genomic research to understand cancer variations; Collaborate with global partners for cancer innovation; Improve precision oncology practices in Africa; Transform cancer care through inclusive research.
Who are the founders of Yemaachi Biotech
Market Focus
Yemaachi Biotech primarily focuses on the biotechnology industry, specifically in clinical genomic research and the development of cancer drugs tailored for diverse populations.
Competitors Overview
Yemaachi Biotech operates in the biotechnology sector, focusing on cancer drug development and genomic research in Africa. Its main competitors include:
- 54Gene: This company specializes in genomic data representation and aims to improve healthcare outcomes in Africa through genomic research.
Investors
- Yemaachi Biotech has attracted over $4 million in investment.
- The funding primarily comes from African investors and the Bill and Melinda Gates Foundation.
Full Description
Yemaachi Biotech focuses on creating a comprehensive cancer bio-database to develop innovative cancer drugs. Their unique approach emphasizes inclusivity and diversity in cancer research, particularly for populations in Africa. This work aims to transform cancer care and improve outcomes for diverse patient groups globally.
Other Considerations
Supported by a global network of partners; Focused on diversifying precision oncology; Team includes scientists and engineers with African roots.
See something that needs updating? Suggest edits to this profile.